Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7597445 | 0.95 | LMNA (0.43) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL17705702 | 0.90 | ALDH1A1 (0.43) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL17705699 | 0.90 | CYP3A4 (0.67) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL486301 | 0.90 | IDO1 (0.59) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| Hydrochloric Acid SCHEMBL4381619 | 0.88 | CYP3A4 (0.56) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL15247738 | 0.81 | NOS3 (0.40) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL218054 | 0.80 | TDP1 (0.67) | LMNAALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL22990410 | 0.80 | HRH3 (0.52) | LMNACYP3A4TDP1CYP1A2CYP2D6 | |
| SCHEMBL9593311 | 0.78 | TBXAS1 (0.51) | ALDH1A1CYP3A4CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL1143908 | 0.78 | TAAR1 (0.48) | LMNAALDH1A1CYP3A4TDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130178437-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-07-11 | — | — | US | disclosed |
| US-20130178437-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-07-11 | — | — | US | disclosed |
| WO-2012004007-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2012-01-12 | — | — | WO | disclosed |
| US-20090035491-A1 | Ink-Jet Recording Material | MITSUBISHI PAPER MILLS LIMITED (JP) | 2009-02-05 | — | — | US | disclosed |
| US-5091466-A | Insolubilization of soluble pre-imidized polyimides by polyhydrazine compounds | GENERAL ELECTRIC COMPANY (US) | 1992-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178437-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | SI, HASPIN, HPN | LMNA 57/4885ALDH1A1 840/4885CYP3A4 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.